Biostar Pharmaceuticals, Inc. Retained Earnings
Biostar Pharmaceuticals, Inc. had Retained Earnings of -$4.99 million as of 2017-09-30, per its 10-Q filed 2017-11-20.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent › Retained Earnings (Accumulated Deficit)
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2017-11-20
- 2017-09-30: Retained Earnings (Accumulated Deficit) -$4.99M.
- 2017-06-30: Retained Earnings (Accumulated Deficit) -$4.87M.
- 2017-03-31: Retained Earnings (Accumulated Deficit) -$3.56M.
- 2016-12-31: Retained Earnings (Accumulated Deficit) -$2.54M.
| Period end | Retained Earnings (Accumulated Deficit) |
|---|---|
| 2017-09-30 | -$4.99M 10-Q · filed 2017-11-20 |
| 2017-06-30 | -$4.87M 10-Q · filed 2017-11-15 |
| 2017-03-31 | -$3.56M 10-Q · filed 2017-05-19 |
| 2016-12-31 | -$2.54M 10-Q · filed 2017-11-20 |
| 2016-09-30 | -$5.93M 10-Q · filed 2016-11-21 |
| 2016-06-30 | -$4.37M 10-Q · filed 2016-08-22 |
| 2016-03-31 | $2.54M 10-Q · filed 2016-05-23 |
| 2015-12-31 | $3.16M 10-K · filed 2017-04-13 |
| 2015-09-30 | $26.36M 10-Q · filed 2015-11-23 |
| 2015-06-30 | $27.62M 10-Q · filed 2015-08-19 |
| 2015-03-31 | $28.11M 10-Q · filed 2015-05-15 |
| 2014-12-31 | $28.27M 10-K · filed 2016-04-14 |
| 2014-09-30 | $25.84M 10-Q · filed 2014-11-14 |
| 2014-06-30 | $25.60M 10-Q · filed 2014-08-14 |
| 2014-03-31 | $23.96M 10-Q · filed 2014-05-15 |
| 2013-12-31 | $23.65M 10-K · filed 2015-04-15 |
| 2013-09-30 | $23.45M 10-Q · filed 2013-11-14 |
| 2013-06-30 | $23.06M 10-Q · filed 2013-08-19 |
| 2013-03-31 | $23.79M 10-Q · filed 2013-05-15 |
| 2012-12-31 | $23.23M 10-K · filed 2014-03-31 |
| 2012-09-30 | $30.22M 10-Q · filed 2012-11-19 |
| 2012-06-30 | $36.16M 10-Q · filed 2012-08-14 |
| 2012-03-31 | $45.64M 10-Q · filed 2012-05-15 |
| 2011-12-31 | $43.47M 10-K · filed 2013-04-15 |
| 2011-09-30 | $44.46M 10-Q · filed 2011-11-14 |
| 2011-06-30 | $40.00M 10-Q · filed 2011-08-15 |
| 2010-12-31 | $33.12M 10-K · filed 2012-03-27 |